N/A N=77 Modeling Multi-level Dyadic Behavior to Transform the Science and Practice of Psychotherapy Process and Outcome.
Major Depressive Disorder
Primary: Depression Severity — 11.9; 11.41 score on a scale — p=.752
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=25 Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Latent Tuberculosis
Primary: Feasibility: Participant Attendance — 10; 9; 7; 8 participants
N/A N=179 Persistent Postoperative Pain and Joint Stiffness After Total Knee Arthroplasty Performed for Osteoarthritis
Pain · Joint Stiffness
Primary: Presence of Persistent Postoperative Pain Using the Numeric Rating Scale (NRS) — 10 Participants
Phase 3 N=41 Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
Psoriatic Arthritis
Primary: ACR20 Response at Week 16 — 14; 6 Participants
N/A N=35 Improving Housing Outcomes for Homeless Veterans
Veterans · Homeless Persons · Mentally Ill Persons
Primary: Client Satisfaction Questionnaire - 8 — 26.2 score on a scale
Phase 2 N=620 Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy
Plasmodium Falciparum
Primary: Time to First PCR-detectable Malaria Infection During the Active Detection of Infection (ADI) Phase in Groups 1 and 4 — 1.01; 1.49 Events per person year at risk — p=0.009
Phase 4 N=24 Steroid-reducing Effects of Crisaborole
Atopic Dermatitis · Eczema
Primary: Steroid Usage Quantity — 7.27; 10.78; 8.22 grams
Phase 3 N=70 A Phase II/III Study of Sargramostim
COVID-19
Primary: 2-rank Improvement on a 7-point Ordinal Scale — 9; 8 Number of Days
N/A N=122 Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
Pulmonary Embolism · Acute Pulmonary Embolism
Primary: Change in Right Ventricle to Left Ventricle (RV/LV) Ratio Between Baseline and 48 Hours Post-procedure Assessed by Computed Tomography Angiography (CTA) — -0.45 ratio
Phase 3 N=24 Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With · Glucocorticoid-induced Osteoporosis
Primary: Change From Baseline in Lumbar Spine BMD Z-score as Assessed by Dual-energy X-ray Absorptiometry (DXA) at 12 Months — 0.23; 0.11 Z-score — p=0.68
Phase 2 N=10 A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44
Healthy
Primary: Visual Evaluation of MRE Images - Motility — 0; 6; 4; 0 Participants
N/A N=41 An Assessment of Bone Augmentation in Post-Extraction Sockets
Unrestorable Dentition · Post-Extraction Sockets
Primary: Bone-fill in Grafted Post-extraction Sockets Versus Bone-fill in Non-grafted Post-extraction Sockets — 0.43; 0.27; 0.36; 0.28 mm
N/A N=1,205 Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries
Kidney Neoplasms
Primary: Number of Participants With at Least 1 Filled Sunitinib Prescription — 704; 320; 71; 53 Participants
Phase 3 N=110 A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
Hereditary Angioedema
Primary: Time to Beginning of Symptom Relief Patient Global Impression of Change (PGI-C) — 1.61; 1.79; 6.72 Time (h) — p=<0.0001
Phase 4 N=307 Comparison of Misoprostol Ripening Efficacy With Dilapan
Labor Onset and Length Abnormalities · Induced; Birth
Primary: Number of Women Achieving Vaginal Delivery Within 36 Hours After Initiation of Cervical Ripening in ITT Population — 93; 90 Participants